by Okapit | Sep 22, 2023 | Uncategorized
Our CEO, Tuija Keinonen, will give a presentation titled ‘Rokote Approach for Nasal Vaccination’ at the World Vaccine Congress Europe in Barcelona on Tuesday, October 17th, at 12:05 PM. We are delighted to have this opportunity to discuss intranasal...
by Okapit | Sep 18, 2023 | Uncategorized
Following the completion of the research and development phase for Rokote Laboratories Finland Oy’s FINCoVac 2.1 coronavirus vaccine in early summer, the vaccine has advanced to the next stage in the production process at a designated contract manufacturer. This...
by Okapit | Apr 5, 2023 | Uncategorized
Rokote Laboratories Finland Oy is developing a coronavirus vaccine and the clinical trials should start during 2023. The development of the company’s FINCoVac vaccine has been rapid as it is based on knowledge gained from long-term research. Despite this, the journey...
by Okapit | Jan 20, 2023 | Uncategorized
The nasal COVID-19 vaccine can suppress the infection before the symptoms even appear. People who are not infected would not spread the disease and the pandemic could come to its end. Rokote Laboratories Finland Ltd is one of the few European companies, if not the...
by Okapit | Dec 15, 2022 | Uncategorized
The purpose of the funding granted by Sitra is to expedite the popularisation of decentralised and virtual research methods in Finland. Rokote Laboratories Finland Ltd will use the funding to prepare a research plan and application for a phase 1a clinical trial of a...
